NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs...
13 Elo 17min
NRG2026 and Glioblastoma Awareness Day Special
For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.
15 Heinä 38min
Uterine Cancer Awareness Month 2026
This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus S...
23 Kesä 49min
Prostate Cancer Analysis and Translational Science from ASCO 2026
In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.
30 Touko 29min
NRG-GY018 Mature Results from ASCO 2026
Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.
29 Touko 18min
Special Episode with ASTRO’s CEO for ASTRO Advocacy Day
The NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and overcoming obstacles in radi...
27 Huhti 31min
NRG-GY019 Plenary Presentation at SGO 2026
Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.
10 Huhti 17min
